| Application no. and date | 02711823.1 (espacenet) (Federated) (European Patent Register), 20020118 | | Patent/reg. no. and date | DK/EP 1355650, 20051228 | | Publication date | 20031029 | | Priority no. and date | EP 01400166, 20010119 | | EP pub. no. and date |
EP 1355650 20031029 | | Effective date | | | Applicant/owner | Sanofi-Aventis, 174, Avenue de France
75013 Paris, FR | | Applicant ref. no. | AVENT SANSYL077 | | Inventor | ARBILLA, Sonia, 16, rue J.M. de Hérédia
F-75007 Paris, FR,
RAMIREZ, Juan Fernando, Crest Ct Sadohara 514,
2-1-4.Ichigaya Sadohara-CHO
injuku-ku,
Tokyo, JP | | Representative | | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 15/10 (2006.01) | | Title | Kombination af aktive bestanddele, som indeholder alfuzosin og apomorphin | | Int. application no. | EP2002001051 | | Int. publication no. | WO2002056887 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
